Modifications in Upper Airway Collapsibility during Sleep Endoscopy with a Mandibular Positioner: Study in Snorers and Obstructive Sleep Apnea Patients.

Drug-Induced Sleep Endoscopy (DISE) collapsibility mandibular advancement device (MAD) obstructive sleep apnea (OSA) titratable positioner

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
20 Feb 2024
Historique:
received: 20 01 2024
revised: 06 02 2024
accepted: 13 02 2024
medline: 9 4 2024
pubmed: 9 4 2024
entrez: 9 4 2024
Statut: epublish

Résumé

Mandibular advancement devices (MADs) are an effective treatment for patients with sleep-related breathing disorders, with variable response. Increasingly more research points to the predictive value of Drug-Induced Sleep Endoscopy (DISE) in patient selection. This study aims to analyze the changes in upper airway collapsibility using a titratable MAD simulator during DISE. This study included 104 patients with simple snoring and obstructive sleep apnea (OSA). The VOTE scale was used to assess the presence of collapses during the DISE both without and with the MAD simulator. In snorers, there was a decrease in collapses at the level of the soft palate and oropharynx when the advancement was achieved. Patients with mild OSA also showed a decrease in collapses at the base of the tongue. Patients with moderate/severe OSA exhibited significant amelioration at all levels. The levels at which there were residual collapses despite the maneuver were, in order, the velopharynx, oropharynx, epiglottis, and tongue. The MAD simulator reduces collapsibility at all levels and in all severity groups. Residual collapses suitable for combined treatments were able to be identified. This highlights the need for individualized patient selection, as upper airway collapsibility exhibits variable improvement or worsening with the MAD simulator regardless of the severity of the condition.

Sections du résumé

BACKGROUND BACKGROUND
Mandibular advancement devices (MADs) are an effective treatment for patients with sleep-related breathing disorders, with variable response. Increasingly more research points to the predictive value of Drug-Induced Sleep Endoscopy (DISE) in patient selection. This study aims to analyze the changes in upper airway collapsibility using a titratable MAD simulator during DISE.
METHODS METHODS
This study included 104 patients with simple snoring and obstructive sleep apnea (OSA). The VOTE scale was used to assess the presence of collapses during the DISE both without and with the MAD simulator.
RESULTS RESULTS
In snorers, there was a decrease in collapses at the level of the soft palate and oropharynx when the advancement was achieved. Patients with mild OSA also showed a decrease in collapses at the base of the tongue. Patients with moderate/severe OSA exhibited significant amelioration at all levels. The levels at which there were residual collapses despite the maneuver were, in order, the velopharynx, oropharynx, epiglottis, and tongue.
CONCLUSIONS CONCLUSIONS
The MAD simulator reduces collapsibility at all levels and in all severity groups. Residual collapses suitable for combined treatments were able to be identified. This highlights the need for individualized patient selection, as upper airway collapsibility exhibits variable improvement or worsening with the MAD simulator regardless of the severity of the condition.

Identifiants

pubmed: 38592035
pii: jcm13051184
doi: 10.3390/jcm13051184
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Patricia Fernández-Sanjuán (P)

Sleep Respiratory Disorders Unit, Hospital Universitario La Zarzuela, 28023 Madrid, Spain.
Universidad Rey Juan Carlos, 28002 Madrid, Spain.

Marta Alcaraz (M)

Department of Otolaryngology, Hospital Universitario La Moraleja, 28050 Madrid, Spain.

Gabriela Bosco (G)

Sleep Respiratory Disorders Unit, Hospital Universitario La Zarzuela, 28023 Madrid, Spain.
Department of Otolaryngology, Hospital Universitario de Fuenlabrada, 28942 Madrid, Spain.
Department of Otolaryngology, Hospital Universitario La Zarzuela, 28023 Madrid, Spain.

Nuria Pérez-Martín (N)

Sleep Respiratory Disorders Unit, Hospital Universitario La Zarzuela, 28023 Madrid, Spain.
Department of Otolaryngology, Hospital Universitario de Fuenlabrada, 28942 Madrid, Spain.
Department of Otolaryngology, Hospital Universitario La Zarzuela, 28023 Madrid, Spain.

Marta Morato (M)

Department of Otolaryngology, Hospital Quirónsalud San José, 28002 Madrid, Spain.

Rodolfo Lugo (R)

Department of Otolaryngology Head and Neck Surgery, Hospital San José, Monterrey 64718, Mexico.

Juan José Arrieta (JJ)

Department of Stomatology, Hospital Universitario Fundación Jiménez Díaz, 28040 Madrid, Spain.

Jaime Sanabria (J)

Department of Otolaryngology Head and Neck Surgery, Hospital Universitario Fundación Jiménez Díaz, 28040 Madrid, Spain.

Marcos Ríos-Lago (M)

Department of Basic Psychology II, Faculty of Psychology, UNED-Universidad Nacional de Educación a Distancia, 28040 Madrid, Spain.

Guillermo Plaza (G)

Sleep Respiratory Disorders Unit, Hospital Universitario La Zarzuela, 28023 Madrid, Spain.
Universidad Rey Juan Carlos, 28002 Madrid, Spain.
Department of Otolaryngology, Hospital Universitario de Fuenlabrada, 28942 Madrid, Spain.
Department of Otolaryngology, Hospital Universitario La Zarzuela, 28023 Madrid, Spain.

Classifications MeSH